(4) Although PRR14 shows almost no impact on endocrine therapy (Fig. 8e), CHEK2 and PRR14 have opposite impacts on breast cancer patients receiving chemotherapy (Fig. 8a–c). This evidence concerns the gene PRR14 and breast cancer.